Why InterMune, Zulily, and Infinity Pharmaceuticals Are Today's 3 Best Stocks
Economic data pushes the S&P 500 marginally lower as InterMune, Zulily, and Infinity Pharmaceuticals all exploded higher.
Why Infinity Pharmaceuticals Inc. Shares Jumped
Shares of Infinity Pharmaceuticals jump by double-digits after reporting its fourth-quarter earnings results. Find out why investors would be wise to overlook the headline number and focus on this figure instead.
The Hidden Gems in Gilead Sciences' Pipeline
Gilead investors should look beyond the company’s antiviral portfolio and take a closer look at these hidden gems in its pipeline, which could shape the company’s long-term future.
Synta Pharmaceuticals: 4 Key Investing Takeaways From 2013
Let’s take a look at 4 key investing takeaways from Synta’s volatile year, and how larger companies, like Infinity Pharmaceuticals, Roche, and GlaxoSmithKline, fit into the company’s growth prospects for 2014.